These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31658912)

  • 1. Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
    Brucato G; First MB; Dishy GA; Samuel SS; Xu Q; Wall MM; Small SA; Masucci MD; Lieberman JA; Girgis RR
    Psychol Med; 2021 Jan; 51(1):112-120. PubMed ID: 31658912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal relationship between onset of positive and negative symptoms in the course of attenuated psychotic illness.
    Dishy G; Kennedy L; Lundgren B; Xu Q; Masucci MD; Califano A; Hesson H; Cohen-Romano C; Pia T; Brucato G
    Psychiatry Res; 2020 Nov; 293():113439. PubMed ID: 32942088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affect recognition in people at clinical high risk of psychosis.
    Addington J; Piskulic D; Perkins D; Woods SW; Liu L; Penn DL
    Schizophr Res; 2012 Sep; 140(1-3):87-92. PubMed ID: 22763425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in symptom content from a clinical high-risk state to conversion to psychosis.
    Marshall C; Lu Y; Lyngberg K; Deighton S; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon D; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):257-263. PubMed ID: 28771938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.
    Zhang T; Li H; Woodberry KA; Seidman LJ; Zheng L; Li H; Zhao S; Tang Y; Guo Q; Lu X; Zhuo K; Qian Z; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Schizophr Res; 2014 Feb; 152(2-3):391-9. PubMed ID: 24387999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Brucato G; Masucci MD; Arndt LY; Ben-David S; Colibazzi T; Corcoran CM; Crumbley AH; Crump FM; Gill KE; Kimhy D; Lister A; Schobel SA; Yang LH; Lieberman JA; Girgis RR
    Psychol Med; 2017 Aug; 47(11):1923-1935. PubMed ID: 28249639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of at-risk symptoms for psychosis in children and adolescents.
    Schimmelmann BG; Walger P; Schultze-Lutter F
    Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state.
    Maurer K; Zink M; Rausch F; Häfner H
    Early Interv Psychiatry; 2018 Apr; 12(2):217-228. PubMed ID: 26801553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated first-rank symptoms and conversion to psychosis in a clinical high-risk cohort.
    Crump FM; Arndt L; Grivel M; Horga G; Corcoran CM; Brucato G; Girgis RR
    Early Interv Psychiatry; 2018 Dec; 12(6):1213-1216. PubMed ID: 29230968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.
    Carrión RE; Correll CU; Auther AM; Cornblatt BA
    Schizophr Bull; 2017 Jan; 43(1):64-74. PubMed ID: 28053131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A predictive model for conversion to psychosis in clinical high-risk patients.
    Ciarleglio AJ; Brucato G; Masucci MD; Altschuler R; Colibazzi T; Corcoran CM; Crump FM; Horga G; Lehembre-Shiah E; Leong W; Schobel SA; Wall MM; Yang LH; Lieberman JA; Girgis RR
    Psychol Med; 2019 May; 49(7):1128-1137. PubMed ID: 29950184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.